Regulatory Spotlight // Accelerating Innovation in Market & Regulatory Complexity
- Lack of alignment and fragmented lobbying across Europe with regulatory delays are slowing the progress of biologicals and New Genomic Techniques (NGTs), hindering the adoption of innovative solutions that could replace traditional chemistry. What would it take to present a unified industry voice to regulators and policymakers in Europe?
- How can companies navigate innovation bottlenecks when faced with regulatory uncertainty and delays? How could cross-industry collaboration, involving agribusinesses, start-ups, and associations, help move the needle faster and overcome these challenges?